[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

September 2016 | 102 pages | ID: E34526C9F78EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Drugs for Respiratory Syncytial Virus (RSV)

Revenue, means the sales value of Drugs for Respiratory Syncytial Virus (RSV)

This report studies sales (consumption) of Drugs for Respiratory Syncytial Virus (RSV) in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Ablynx
  • ADMA Biologics
  • Agilvax
  • AlphaVax
  • AmVac
  • Aridis Pharmaceuticals
  • Artificial Cell Technologies
  • Astellas Pharma
  • AstraZeneca
  • Bavarian Nordic
  • Biota Pharmaceuticals
  • Celltrion
  • Codagenix
  • Crucell
  • CureVac
  • Emergent
  • Roche
  • GenVec
  • Gilead Sciences
  • GlaxoSmithKline
  • Humabs BioMed
  • Novavax
Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Drugs for Respiratory Syncytial Virus (RSV) in these regions, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Ribavirin
  • Bronchodilator
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Drugs for Respiratory Syncytial Virus (RSV) in each application, can be divided into
  • Infants (Under 6 Month Old)
  • Babies & Children
  • Adults
1 DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) OVERVIEW

1.1 Product Overview and Scope of Drugs for Respiratory Syncytial Virus (RSV)
1.2 Classification of Drugs for Respiratory Syncytial Virus (RSV)
  1.2.1 Ribavirin
  1.2.2 Bronchodilator
  1.2.3 Type III
1.3 Applications of Drugs for Respiratory Syncytial Virus (RSV)
  1.3.1 Infants (Under 6 Month Old)
  1.3.2 Babies & Children
  1.3.3 Adults
1.4 Drugs for Respiratory Syncytial Virus (RSV) Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Drugs for Respiratory Syncytial Virus (RSV) (2011-2021)
  1.5.1 Europe Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
  1.5.3 Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)

2 EUROPE DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Drugs for Respiratory Syncytial Virus (RSV) Market Competition by Manufacturers
  2.1.1 Europe Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Drugs for Respiratory Syncytial Virus (RSV) (Volume and Value) by Type
  2.2.1 Europe Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)
2.3 Europe Drugs for Respiratory Syncytial Virus (RSV) (Volume and Value) by Regions
  2.3.1 Europe Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Regions (2011-2021)
2.4 Europe Drugs for Respiratory Syncytial Virus (RSV) (Volume) by Application

3 GERMANY DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Drugs for Respiratory Syncytial Virus (RSV) Sales and Value (2011-2021)
  3.1.1 Germany Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
  3.1.2 Germany Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
3.2 Germany Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Manufacturers
3.3 Germany Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type
3.4 Germany Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Applications

4 UK DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) (VOLUME, VALUE AND SALES PRICE)

4.1 UK Drugs for Respiratory Syncytial Virus (RSV) Sales and Value (2011-2021)
  4.1.1 UK Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
  4.1.2 UK Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
  4.1.3 UK Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
4.2 UK Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Manufacturers
4.3 UK Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type
4.4 UK Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Applications

5 FRANCE DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) (VOLUME, VALUE AND SALES PRICE)

5.1 France Drugs for Respiratory Syncytial Virus (RSV) Sales and Value (2011-2021)
  5.1.1 France Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
  5.1.2 France Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
  5.1.3 France Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
5.2 France Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Manufacturers
5.3 France Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type
5.4 France Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Applications

6 ITALY DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Drugs for Respiratory Syncytial Virus (RSV) Sales and Value (2011-2021)
  6.1.1 Italy Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
  6.1.2 Italy Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
6.2 Italy Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Manufacturers
6.3 Italy Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type
6.4 Italy Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Applications

7 RUSSIA DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Drugs for Respiratory Syncytial Virus (RSV) Sales and Value (2011-2021)
  7.1.1 Russia Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
  7.1.2 Russia Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
7.2 Russia Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Manufacturers
7.3 Russia Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type
7.4 Russia Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Applications

8 SPAIN DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Drugs for Respiratory Syncytial Virus (RSV) Sales and Value (2011-2021)
  8.1.1 Spain Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
  8.1.2 Spain Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
8.2 Spain Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Manufacturers
8.3 Spain Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type
8.4 Spain Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Applications

9 EUROPE DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) MANUFACTURERS ANALYSIS

9.1 Ablynx
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
9.2 ADMA Biologics
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
9.3 Agilvax
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Agilvax (2015 and 2016)
9.4 AlphaVax
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AlphaVax (2015 and 2016)
9.5 AmVac
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AmVac (2015 and 2016)
9.6 Aridis Pharmaceuticals
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
9.7 Artificial Cell Technologies
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
9.8 Astellas Pharma
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
9.9 AstraZeneca
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AstraZeneca (2015 and 2016)
9.10 Bavarian Nordic
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
9.11 Biota Pharmaceuticals
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.11.2.1 Type I
    9.11.2.2 Type II
  9.11.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Biota Pharmaceuticals (2015 and 2016)
9.12 Celltrion
  9.12.1 Company Basic Information,Manufacturing Base and Competitors
  9.12.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.12.2.1 Type I
    9.12.2.2 Type II
  9.12.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Celltrion (2015 and 2016)
9.13 Codagenix
  9.13.1 Company Basic Information,Manufacturing Base and Competitors
  9.13.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.13.2.1 Type I
    9.13.2.2 Type II
  9.13.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Codagenix (2015 and 2016)
9.14 Crucell
  9.14.1 Company Basic Information,Manufacturing Base and Competitors
  9.14.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.14.2.1 Type I
    9.14.2.2 Type II
  9.14.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Crucell (2015 and 2016)
9.15 CureVac
  9.15.1 Company Basic Information,Manufacturing Base and Competitors
  9.15.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.15.2.1 Type I
    9.15.2.2 Type II
  9.15.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of CureVac (2015 and 2016)
9.16 Emergent
  9.16.1 Company Basic Information,Manufacturing Base and Competitors
  9.16.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.16.2.1 Type I
    9.16.2.2 Type II
  9.16.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Emergent (2015 and 2016)
9.17 Roche
  9.17.1 Company Basic Information,Manufacturing Base and Competitors
  9.17.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.17.2.1 Type I
    9.17.2.2 Type II
  9.17.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Roche (2015 and 2016)
9.18 GenVec
  9.18.1 Company Basic Information,Manufacturing Base and Competitors
  9.18.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.18.2.1 Type I
    9.18.2.2 Type II
  9.18.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GenVec (2015 and 2016)
9.19 Gilead Sciences
  9.19.1 Company Basic Information,Manufacturing Base and Competitors
  9.19.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.19.2.1 Type I
    9.19.2.2 Type II
  9.19.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
9.20 GlaxoSmithKline
  9.20.1 Company Basic Information,Manufacturing Base and Competitors
  9.20.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.20.2.1 Type I
    9.20.2.2 Type II
  9.20.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
9.21 Humabs BioMed
  9.21.1 Company Basic Information,Manufacturing Base and Competitors
  9.21.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.21.2.1 Type I
    9.21.2.2 Type II
  9.21.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Humabs BioMed (2015 and 2016)
9.22 Novavax
  9.22.1 Company Basic Information,Manufacturing Base and Competitors
  9.22.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    9.22.2.1 Type I
    9.22.2.2 Type II
  9.22.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Novavax (2015 and 2016)

10 DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) TECHNOLOGY AND DEVELOPMENT TREND

10.1 Drugs for Respiratory Syncytial Virus (RSV) Technology Analysis
10.2 Drugs for Respiratory Syncytial Virus (RSV) Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Respiratory Syncytial Virus (RSV)
Table Classification of Drugs for Respiratory Syncytial Virus (RSV)
Figure Europe Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Types in 2015
Figure Ribavirin Picture
Figure Bronchodilator Picture
Table Applications of Drugs for Respiratory Syncytial Virus (RSV)
Figure Europe Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Applications in 2015
Figure Infants (Under 6 Month Old) Examples
Figure Babies & Children Examples
Figure Adults Examples
Figure Germany Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure France Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure UK Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Italy Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Spain Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Russia Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales of Key Manufacturers (2015 and 2016)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Figure 2016 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue by Manufacturers (2015 and 2016)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table 2016 Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Type (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Type (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue Growth Rate by Type (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Regions (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Regions (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Regions (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Regions (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue Growth Rate by Regions (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Application (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Application (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2011-2021)
Figure Germany Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure Germany Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Germany Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
Table Germany Drugs for Respiratory Syncytial Virus (RSV) Sales by Manufacturers (2015 and 2016)
Table Germany Drugs for Respiratory Syncytial Virus (RSV) Market Share by Manufacturers (2015 and 2016)
Table Germany Drugs for Respiratory Syncytial Virus (RSV) Sales by Type (2015 and 2016)
Table Germany Drugs for Respiratory Syncytial Virus (RSV) Market Share by Type (2015 and 2016)
Table Germany Drugs for Respiratory Syncytial Virus (RSV) Sales by Applications (2015 and 2016)
Table Germany Drugs for Respiratory Syncytial Virus (RSV) Market Share by Applications (2015 and 2016)
Figure UK Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure UK Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure UK Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
Table UK Drugs for Respiratory Syncytial Virus (RSV) Sales by Manufacturers (2015 and 2016)
Table UK Drugs for Respiratory Syncytial Virus (RSV) Market Share by Manufacturers (2015 and 2016)
Table UK Drugs for Respiratory Syncytial Virus (RSV) Sales by Type (2015 and 2016)
Table UK Drugs for Respiratory Syncytial Virus (RSV) Market Share by Type (2015 and 2016)
Table UK Drugs for Respiratory Syncytial Virus (RSV) Sales by Applications (2015 and 2016)
Table UK Drugs for Respiratory Syncytial Virus (RSV) Market Share by Applications (2015 and 2016)
Figure France Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure France Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure France Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
Table France Drugs for Respiratory Syncytial Virus (RSV) Sales by Manufacturers (2015 and 2016)
Table France Drugs for Respiratory Syncytial Virus (RSV) Market Share by Manufacturers (2015 and 2016)
Table France Drugs for Respiratory Syncytial Virus (RSV) Sales by Type (2015 and 2016)
Table France Drugs for Respiratory Syncytial Virus (RSV) Market Share by Type (2015 and 2016)
Table France Drugs for Respiratory Syncytial Virus (RSV) Sales by Applications (2015 and 2016)
Table France Drugs for Respiratory Syncytial Virus (RSV) Market Share by Applications (2015 and 2016)
Figure Italy Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure Italy Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Italy Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
Table Italy Drugs for Respiratory Syncytial Virus (RSV) Sales by Manufacturers (2015 and 2016)
Table Italy Drugs for Respiratory Syncytial Virus (RSV) Market Share by Manufacturers (2015 and 2016)
Table Italy Drugs for Respiratory Syncytial Virus (RSV) Sales by Type (2015 and 2016)
Table Italy Drugs for Respiratory Syncytial Virus (RSV) Market Share by Type (2015 and 2016)
Table Italy Drugs for Respiratory Syncytial Virus (RSV) Sales by Applications (2015 and 2016)
Table Italy Drugs for Respiratory Syncytial Virus (RSV) Market Share by Applications (2015 and 2016)
Figure Russia Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure Russia Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Russia Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
Table Russia Drugs for Respiratory Syncytial Virus (RSV) Sales by Manufacturers (2015 and 2016)
Table Russia Drugs for Respiratory Syncytial Virus (RSV) Market Share by Manufacturers (2015 and 2016)
Table Russia Drugs for Respiratory Syncytial Virus (RSV) Sales by Type (2015 and 2016)
Table Russia Drugs for Respiratory Syncytial Virus (RSV) Market Share by Type (2015 and 2016)
Table Russia Drugs for Respiratory Syncytial Virus (RSV) Sales by Applications (2015 and 2016)
Table Russia Drugs for Respiratory Syncytial Virus (RSV) Market Share by Applications (2015 and 2016)
Figure Spain Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure Spain Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Spain Drugs for Respiratory Syncytial Virus (RSV) Sales Price Trend (2011-2021)
Table Spain Drugs for Respiratory Syncytial Virus (RSV) Sales by Manufacturers (2015 and 2016)
Table Spain Drugs for Respiratory Syncytial Virus (RSV) Market Share by Manufacturers (2015 and 2016)
Table Spain Drugs for Respiratory Syncytial Virus (RSV) Sales by Type (2015 and 2016)
Table Spain Drugs for Respiratory Syncytial Virus (RSV) Market Share by Type (2015 and 2016)
Table Spain Drugs for Respiratory Syncytial Virus (RSV) Sales by Applications (2015 and 2016)
Table Spain Drugs for Respiratory Syncytial Virus (RSV) Market Share by Applications (2015 and 2016)
Table Ablynx Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
Table ADMA Biologics Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
Table Agilvax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Agilvax (2015 and 2016)
Table AlphaVax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AlphaVax (2015 and 2016)
Table AmVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AmVac (2015 and 2016)
Table Aridis Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
Table Artificial Cell Technologies Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table AstraZeneca Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Bavarian Nordic Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories